Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer

Figure 6

Strategies of pharmacologic redifferentiation of radioiodine refractory thyroid cancer by intervening genetic and epigenetic alterations and dysregulated signaling pathways related to the cancer.